Benign essential blepharospasm (BEB)
Overview
Benign essential blepharospasm (BEB) is a chronic neurological movement disorder marked by involuntary, repetitive spasms and contractions of the eyelid muscles. It typically begins with increased blinking or eye irritation, and can progress to forceful, sustained eyelid closures that impair vision.
Symptoms
• Increased blinking: Blinking happens more often and may start in one eye before moving to both eyes.
• Eye irritation: The eyes may feel dry, gritty, or tired.
• Environmental sensitivity: Bright sunlight, wind, air pollution, or dust can make the symptoms worse.
• Involuntary eyelid closing: Spasms become stronger, causing the eyelids to narrow or clamp shut.
• Difficulty keeping eyes open: It becomes hard or impossible to voluntarily keep the eyes open during episodes.
• Functional blindness: In severe cases, prolonged or sustained eyelid closure blocks vision even though the eye structure itself remains healthy.
• Bilateral involvement: Symptoms eventually affect both eyes symmetrically.
• Sensory tricks ("geste antagoniste"): Some people can temporarily stop or reduce the spasms by touching their eyebrow, temple, or cheek.
• Spread to other facial muscles: Spasms may extend to the lower face, jaw (causing clenching or grimacing), or neck (known as Meige syndrome or cranial dystonia).
• Photophobia: Extreme sensitivity to bright lights (affecting up to 79% of patients).
• Relief during sleep: Spasms typically stop completely while sleeping and return after waking.
• Temporary relief activities: Spasms may decrease while talking, singing, laughing, yawning, or concentrating on certain tasks.
• Exacerbating factors: Stress, fatigue, anxiety, reading, watching television, and driving make the spasms worse.
• Emotional impact: Chronic visual disruption can lead to social withdrawal, frustration, anxiety, or depression.
Causes
• Basal Ganglia Dysfunction: Problems in the basal ganglia—the part of the brain that helps coordinate and control voluntary and involuntary muscle movements—lead to a loss of normal inhibitory control.
• Impaired Sensorimotor Integration: The central nervous system fails to filter or process sensory signals properly, causing the brainstem blink reflex circuits to become overly excited.
• Cranial Nerve Overactivity: Abnormal signaling or hyperactivity in the facial nerve (Cranial Nerve VII) triggers simultaneous, forceful contractions of the eyelid muscles (the orbicularis oculi).
• Ocular Surface Irritation: Conditions like chronic dry eye disease, blepharitis, or light sensitivity (photophobia) send constant sensory signals to the trigeminal nerve, which can set off or worsen spasms.
• Genetics and Family History: A small percentage of cases involve a family history of dystonia or essential tremor, sometimes following a "two-hit" model where a genetic vulnerability combines with an environmental trigger.
• Stress and Fatigue: High levels of emotional stress, physical exhaustion, anxiety, or lack of sleep frequently act as immediate symptom triggers.
• Demographics: It most commonly affects individuals in mid-to-late adulthood (ages 50 to 70) and is two to four times more common in women than in men.
• Neurological Disorders: Parkinson's disease, progressive supranuclear palsy, Huntington's disease, or Meige syndrome.
• Medications: Long-term use of dopamine-blocking drugs or neuroleptics can cause tardive dyskinesia, which includes eyelid spasms.
• Local Trauma: Past physical trauma or injury to the face or head.
Diagnosis
• Clinical History: Doctors evaluate the onset, pattern, and triggers of symptoms. BEB typically starts with mild, increased blinking or eye irritation, progressing to bilateral (both eyes) and synchronous spasms of the orbicularis oculi muscles. Spymptoms usually vanish during sleep and may lessen with specific tasks or a "sensory trick" (like touching the face).
• Physical and Neuro-Ophthalmologic Exam: Clinicians observe involuntary, patterned contractions of the eyelids and check for functional impairment.
• Slit-Lamp Examination: Performed to assess the ocular surface and rule out local causes of irritation, such as dry eye syndrome, blepharitis, or trichiasis.
• Exclusion of Secondary Causes: The evaluation aims to differentiate BEB from other conditions, such as:
• Hemifacial spasm (which is usually unilateral/one-sided)
• Meige syndrome (when blepharospasm is combined with lower face, jaw, or tongue dystonia)
• Drug-induced spasms (such as tardive dyskinesia from neuroleptics)
• Severity Scales: Tools like the Jankovic Rating Scale (JRS) or the Blepharospasm Disability Index (BSDI) are often used to measure baseline severity and track responses to treatments like botulinum toxin.
Treatment
1. First-Line Treatment: Botulinum Toxin Injections
• How it works: Injections of botulinum toxin (such as Botox, Xeomin, or Dysport) into the eyelid muscles (orbicularis oculi, corrugator, and procerus) block nerve signals to temporarily relax the muscles.
• Effectiveness: Over 90% to 95% of patients experience significant improvement.
• Timeline: Relief typically begins within 2 to 4 days, peaks around 7 to 10 days, and lasts roughly 3 to 4 months, after which repeat injections are required.
• Side effects: May include temporary eyelid drooping (ptosis), dry eyes, double vision, or blurry vision.
2. Supportive & Non-Pharmacological Care
• Artificial tears & dry eye management: Lubricating eye drops and punctal plugs help manage dry eye symptoms that often worsen spasms.
• FL-41 tinted lenses: Rose- or gray-colored glasses help filter specific wavelengths of light to reduce sensitivity (photophobia) and trigger-induced blinking.
• Lifestyle adjustments: Reducing stress, getting adequate sleep, practicing relaxation techniques, and cutting back on caffeine can help lower spasm frequency.
• Eyelid hygiene: Gentle cleaning of the eyelid margins can control underlying blepharitis.
3. Second-Line Medications
• Oral options: Muscle relaxants or sedatives (such as clonazepam, lorazepam, baclofen, or trihexyphenidyl) are rarely as effective as botulinum toxin and carry systemic side effects like drowsiness, dry mouth, or cognitive slowing. They are usually reserved for mild cases or as temporary adjuncts.
4. Surgical Care
• Myectomy: A surgical procedure to remove part or all of the orbicularis protractor/eyelid muscles is reserved for severe cases that fail to respond to botulinum toxin or involve debilitating apraxia of eyelid opening.
• Frontalis suspension: Sometimes paired with surgery if patients struggle with lifting their eyelids.
Type of Doctor Department : An Ophthalmologist

Comments
Post a Comment